Company: DAWN
Filing Date: 2025-11-04
Form Type: 8-K
Source: 0001193125-25-264608
Chunk: 1

Company: Day One Biopharmaceuticals, Inc.
Filing Date: 2025-11-04
Form: 8-K
Item: Item 7.01
Chunk 1
---
Item 7.01 Regulation FD Disclosure.

On November 4, 2025, the Company updated its corporate presentation. A copy of the updated presentation is attached as Exhibit 99.3 to this report.

The information in this Current Report on Form 8-K, including Exhibit 99.1, Exhibit 99.2 and Exhibit 99.3 to this report, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended (the “ Securities Act”). The information contained in this Current Report on Form 8-K and in the accompanying Exhibit 99.1, Exhibit 99.2 and Exhibit 99.3 shall not be incorporated by reference into any other filing under the Exchange Act or under the Securities Act, except as shall be expressly set forth by specific reference in such filing.